614
Views
38
CrossRef citations to date
0
Altmetric
Original Article

Psychological distress, anger and quality of life in polycystic ovary syndrome: associations with biochemical, phenotypical andsocio-demographic factors

ORCID Icon, , , , , & show all
Pages 128-137 | Received 07 Jun 2016, Accepted 14 Mar 2017, Published online: 06 Apr 2017

References

  • Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84:4006–11.
  • Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745–9.
  • Knochenhauer ES, Key TJ, Kahsar-Miller M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078–82.
  • Asuncion M, Calvo RM, San Millan JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434–8.
  • Zawadzki JK, Dunaif A, Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston (MA): Blackwell Scientific Publications; 1992:377–84.
  • The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25.
  • March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010;2:544–51.
  • Azziz R, Carmina E, Dewailly D, et al. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 2006;91:4237–45.
  • Hardiman O, Pillay OS, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 2003;361:1810–12.
  • Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association?. Endocr Rev 2003;24:302–12.
  • Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223–36.
  • Barnard L, Ferriday D, Guenther N, et al. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod 2007;22:2279–86.
  • Jones GL, Hall JM, Balen AH, Ledger WL. Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review. Hum Reprod Update 2008;14:15–25.
  • Moran LJ, Deeks AA, Gibson-Helm ME, Teede HJ. Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod 2012;27:2082–8.
  • Moran L, Gibson-Helm M, Teede H, Deeks A. Polycystic ovary syndrome: a biopsychosocial understanding in young women to improve knowledge and treatment options. J Psychosom Obstet 2010;31:24–31.
  • Mansson M, Holte J, Landin-Wilhelmsen K, et al. Women with polycystic ovary syndrome are often depressed or anxious – a case control study. Psychoneuroendocrinology 2008;33:1132–8.
  • Benson S, Hahn S, Tan S, et al. Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany. Hum Reprod 2009;24:1446–51.
  • Jedel E, Waern M, Gustafson D, et al. Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index. Hum Reprod 2010;25:450–6.
  • Dokras A, Clifton S, Futterweit W, Wild R. Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol 2011;117:145–52.
  • Dobie DJ, Kivlahan DR, Maynard C, et al. Posttraumatic stress disorder in female veterans: association with self-reported health problems and functional impairment. Arch Intern Med 2004;164:394–400.
  • Klipstein KG, Goldberg JF. Screening for bipolar disorder in women with polycystic ovary syndrome: a pilot study. J Affect Disord 2006;91:205–9.
  • Sonino N, Fava GA, Mani E, et al. Quality of life of hirsute women. Postgrad Med J 1993;69:186–9.
  • Hahn S, Janssen OE, Tan S, et al. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol 2005;153:853–60.
  • Mallon E, Newton JN, Klassen A, et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999;140:672–6.
  • Livadas S, Chaskou S, Kandaraki AA, et al. Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome. Clin Endocrinol (Oxf) 2011;75:698–703.
  • Kerchner A, Lester W, Stuart SP, Dokras A. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril 2009;91:207–12.
  • Keegan A, Liao LM, Boyle M. ‘Hirsutism’: a psychological analysis. J Health Psychol 2003;8:327–45.
  • Rasgon NL, Rao RC, Hwang S, et al. Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. J Affect Disord 2003;74:299–304.
  • Hollinrake E, Abreu A, Maifeld M, et al. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 2007;87:1369–76.
  • Elsenbruch S, Hahn S, Kowalsky D, et al. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:5801–7.
  • Guyatt G, Weaver B, Cronin L, et al. Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated. J Clin Epidemiol 2004;57:1279–87.
  • Coffey S, Bano G, Mason HD. Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36). Gynecol Endocrinol 2006;22:80–6.
  • Ching HL, Burke V, Stuckey BG. Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. Clin Endocrinol (Oxf) 2007;66:373–9.
  • Himelein MJ, Thatcher SS. Depression and body image among women with polycystic ovary syndrome. J Health Psychol 2006a;11:613–25.
  • Himelein MJ, Thatcher SS. Polycystic ovary syndrome and mental health: a review. Obstet Gynecol Surv 2006b;61:723–32.
  • Archer J. Testosterone and human aggression: an evaluation of the challenge hypothesis. Neurosci Biobehav Rev 2006;30:319–45.
  • Van de Poll NE, van Goozen SHM. Hypothalamic involvement in sexuality and hostility: comparative psychological aspects. Prog Brain Res 1992;93:343–61.
  • Derogatis LR, Rickels K, Rock AF. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry 1976;128:280–9.
  • Derogatis LR, The SCL-90-R: administration, scoring and procedures manual. 3rd ed. Minneapolis, MN: National Computer Systems; 1994.
  • Sarno I, Preti E, Prunas A, Madeddu F (eds). SCL-90-R. Symptom Checklist-90-R. Firenze; Giunti Organizzazioni Speciali; 2011.
  • Prunas A, Sarno I, Preti E, et al. Psychometric properties of the Italian version of the SCL-90-R: a study on a large community sample. Eur Psychiatry 2012;27:591–7.
  • Spielberger CD. State-trait anger expression inventory-2 (STAXI-2). Professional manual. Tampa (FL): Psychological Assessment Resources; 1999.
  • Spielberger CD, State-trait-anger-expression-inventory. Palo Alto (CA): Consulting Psychologist Press; 1988.
  • Comunian L, Manuale STAXI-2 state-trait anger expression inventory-2. Adattamento italiano. Firenze: Organizzazioni speciali; 2004.
  • Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473–83.
  • Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 1998;51:1025–36.
  • Apolone G, Mosconi P, Ware J, Questionario sullo stato di salute SF-36. Manuale d’uso e guida all’interpretazione dei risultati [SF-36 quality of life questionnaire. User’s manual and guide to the interpretation of results]. Guerini, Milano; 2000.
  • Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–19.
  • Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998;83:2694–8.
  • Ducluzeau PH, Cousin P, Malvoisin E, et al. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:3626–31.
  • Morley JE, Patrick P, Perry HM. III. Evaluation of assays available to measure free testosterone. Metab Clin Exp 2002;51:554–9.
  • Deeks AA, Gibson-Helm ME, Paul E, Teede HJ. Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression? Hum Reprod 2011;26:1399–407.
  • Cinar N, Kizilarslanoglu MC, Harmanci A, et al. Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome. Hum Reprod 2011;26:3339–45.
  • Balikci A, Erdem M, Keskin U, et al. Depression, anxiety, and anger in patients with polycystic ovary syndrome. Arch Neuropsychiatry 2014;51:328–33.
  • Laggari V, Diareme S, Christogiorgos S, et al. Anxiety and depression in adolescents with polycystic ovary syndrome and Mayer-Rokitansky-Küster-Hauser syndrome. J Psychosom Obstet Gynaecol 2009;30:83–8.
  • Pastore LM, Patrie JT, Morris WL, et al. Depression symptoms and body dissatisfaction association among polycystic ovary syndrome women. J Psychosom Res 2011;71:270–6.
  • Weiner CL, Primeau M, Ehrmann DA. Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls. Psychosom Med 2004;66:356–62.
  • Barry JA, Hardiman PJ, Saxby BK, Kuczmierczyk A. Testosterone and mood dysfunction in women with polycystic ovarian syndrome compared to subfertile controls. J Psychosom Obstet 2011;32:104–11.
  • Erickson J, El-Gabalawy R, Palitsky D, Patten S, Mackenzie CS, Stein MB, Sareen J. Educational attainment as a protective factor for psychiatric disorders: findings from a nationally representative longitudinal study. Depress Anxiety 2016;33:1013–22.
  • De Niet JE, de Koning CM, Pastoor H, et al. Psychological well-being and sexarche in women with polycystic ovary syndrome. Hum Reprod 2010;25:1497–503.
  • Drosdzol A, Skrzypulec V, Plinta R. Quality of life, mental health and self-esteem in hirsute adolescent females. J Psychosom Obstet Gynaecol 2010;31:168–75.
  • Tan S, Hahn S, Benson S, et al. Psychological implications of infertility in women with polycystic ovary syndrome. Hum Reprod 2008;23:2064–71.
  • McCook JG, Reame NE, Thatcher SS. Health-related quality of life issues in women with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs 2005;34:12–20.
  • Troisi A, Moles A, Panepuccia L, et al. Serum cholesterol levels and mood symptoms in the postpartum period. Psychiatry Res 2002;109:213–19.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.